全文获取类型
收费全文 | 136006篇 |
免费 | 9416篇 |
国内免费 | 630篇 |
专业分类
耳鼻咽喉 | 1651篇 |
儿科学 | 3418篇 |
妇产科学 | 2444篇 |
基础医学 | 17376篇 |
口腔科学 | 2896篇 |
临床医学 | 13307篇 |
内科学 | 28006篇 |
皮肤病学 | 1751篇 |
神经病学 | 11946篇 |
特种医学 | 5396篇 |
外科学 | 21819篇 |
综合类 | 1920篇 |
现状与发展 | 1篇 |
一般理论 | 173篇 |
预防医学 | 12397篇 |
眼科学 | 2916篇 |
药学 | 9614篇 |
2篇 | |
中国医学 | 179篇 |
肿瘤学 | 8840篇 |
出版年
2023年 | 671篇 |
2022年 | 1050篇 |
2021年 | 2573篇 |
2020年 | 1466篇 |
2019年 | 2396篇 |
2018年 | 2925篇 |
2017年 | 2112篇 |
2016年 | 2232篇 |
2015年 | 2715篇 |
2014年 | 4015篇 |
2013年 | 6058篇 |
2012年 | 8867篇 |
2011年 | 9436篇 |
2010年 | 5253篇 |
2009年 | 4811篇 |
2008年 | 8383篇 |
2007年 | 8984篇 |
2006年 | 8559篇 |
2005年 | 8713篇 |
2004年 | 8370篇 |
2003年 | 7871篇 |
2002年 | 7678篇 |
2001年 | 1277篇 |
2000年 | 1050篇 |
1999年 | 1397篇 |
1998年 | 1627篇 |
1997年 | 1304篇 |
1996年 | 1251篇 |
1995年 | 1216篇 |
1994年 | 1031篇 |
1993年 | 1005篇 |
1992年 | 840篇 |
1991年 | 867篇 |
1990年 | 757篇 |
1989年 | 735篇 |
1988年 | 756篇 |
1987年 | 737篇 |
1986年 | 761篇 |
1985年 | 835篇 |
1984年 | 909篇 |
1983年 | 867篇 |
1982年 | 1131篇 |
1981年 | 1156篇 |
1980年 | 964篇 |
1979年 | 631篇 |
1978年 | 668篇 |
1977年 | 597篇 |
1976年 | 519篇 |
1975年 | 468篇 |
1974年 | 471篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
11.
Richard Kim Elaine Tan Emily Wang Amit Mahipal Dung-Tsa Chen Biwei Cao Fadzai Masawi Cindy Machado James Yu Dae Won Kim 《The oncologist》2020,25(12):e1893-e1899
Lessons Learned
- The combination of trametinib and sorafenib has an acceptable safety profile, albeit at doses lower than approved for monotherapy.
- Maximum tolerated dose is trametinib 1.5 mg daily and sorafenib 200 mg twice daily.
- The limited anticancer activity observed in this unselected patient population does not support further exploration of trametinib plus sorafenib in patients with hepatocellular carcinoma.
12.
13.
Alexander Real Chierika Ukogu Divya Krishnamoorthy Nicole Zubizarreta Samuel K. Cho Andrew C. Hecht James C. Iatridis 《The spine journal》2019,19(2):225-231
Background Context
Low back pain (LBP) is a common complaint in clinical practice of multifactorial origin. Although obesity has been thought to contribute to LBP primarily by altering the distribution of mechanical loads on the spine, the additional contribution of obesity-related conditions such as diabetes mellitus (DM) to LBP has not been thoroughly examined.Purpose
To determine if there is a relationship between DM and LBP that is independent of body mass index (BMI) in a large cohort of adult survey participants.Study Design
Retrospective analysis of prospectively collected National Health and Nutrition Examination Survey (NHANES) data to characterize associations between LBP, DM, and BMI in adults subdivided into 6 subpopulations: normal weight (BMI 18.5–25), overweight (BMI 25–30), and obese (BMI >30) diabetics and nondiabetics. Diabetes was defined with glycohemoglobin A1c (HbA1c) ≥6.5%.Patient Sample
11,756 participants from NHANES cohort.Outcome Measures
Percentage of LBP reported.Methods
LBP reported in the 1999-2004 miscellaneous pain NHANES questionnaire was the dependent variable examined. Covariates included HbA1c, BMI, age, and family income ratio to poverty as continuous variables as well as race, gender, and smoking as binary variables. Individuals were further subdivided by weight class and diabetes status. Regression and graphical analyses were performed on the study population as a whole and also on subpopulations.Results
Increasing HbA1c did not increase the odds of reporting LBP in the full cohort. However, multivariate logistic regression of the 6 subpopulations revealed that the odds of LBP significantly increased with increasing HbA1c levels in normal weight diabetics. No other subpopulations reported significant relationships between LBP and HbA1c. LBP was also significantly associated with BMI for normal weight diabetics and also for obese subjects regardless of their DM status.Conclusions
LBP is significantly related to DM status, but this relationship is complex and may interact with BMI. These results support the concept that LBP may be improved in normal weight diabetic subjects with improved glycemic control and weight loss, and that all obese LBP subjects may benefit from improved weight loss alone. 相似文献14.
15.
16.
17.
18.
Xinran Liu James Anstey Ron Li Chethan Sarabu Reiri Sono Atul J. Butte 《Applied clinical informatics》2021,12(2):407
Background Machine learning (ML) has captured the attention of many clinicians who may not have formal training in this area but are otherwise increasingly exposed to ML literature that may be relevant to their clinical specialties. ML papers that follow an outcomes-based research format can be assessed using clinical research appraisal frameworks such as PICO (Population, Intervention, Comparison, Outcome). However, the PICO frameworks strain when applied to ML papers that create new ML models, which are akin to diagnostic tests. There is a need for a new framework to help assess such papers. Objective We propose a new framework to help clinicians systematically read and evaluate medical ML papers whose aim is to create a new ML model: ML-PICO (Machine Learning, Population, Identification, Crosscheck, Outcomes). We describe how the ML-PICO framework can be applied toward appraising literature describing ML models for health care. Conclusion The relevance of ML to practitioners of clinical medicine is steadily increasing with a growing body of literature. Therefore, it is increasingly important for clinicians to be familiar with how to assess and best utilize these tools. In this paper we have described a practical framework on how to read ML papers that create a new ML model (or diagnostic test): ML-PICO. We hope that this can be used by clinicians to better evaluate the quality and utility of ML papers. 相似文献
19.
20.